Cross Country Healthcare Stock Five Year Return
| CCRN Stock | USD 10.87 0.53 5.13% |
Cross Country Healthcare fundamentals help investors to digest information that contributes to Cross Country's financial success or failures. It also enables traders to predict the movement of Cross Stock. The fundamental analysis module provides a way to measure Cross Country's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cross Country stock.
Cross |
Cross Country Healthcare Company Five Year Return Analysis
Cross Country's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Cross Country Healthcare has a Five Year Return of 0.0%. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Cross Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cross Country's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cross Country could also be used in its relative valuation, which is a method of valuing Cross Country by comparing valuation metrics of similar companies.Cross Country is currently under evaluation in five year return category among its peers.
Cross Fundamentals
| Return On Equity | -0.004 | ||||
| Return On Asset | 0.0127 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 280.75 M | ||||
| Shares Outstanding | 32.92 M | ||||
| Shares Owned By Insiders | 5.58 % | ||||
| Shares Owned By Institutions | 94.42 % | ||||
| Number Of Shares Shorted | 2.87 M | ||||
| Price To Earning | 5.59 X | ||||
| Price To Book | 0.80 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 2.02 B | ||||
| Gross Profit | 627.69 M | ||||
| EBITDA | 129.34 M | ||||
| Net Income | 72.63 M | ||||
| Cash And Equivalents | 279 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 5.27 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 2.67 X | ||||
| Book Value Per Share | 12.24 X | ||||
| Cash Flow From Operations | 248.5 M | ||||
| Short Ratio | 2.69 X | ||||
| Earnings Per Share | (0.05) X | ||||
| Price To Earnings To Growth | 1.81 X | ||||
| Target Price | 15.6 | ||||
| Number Of Employees | 13.13 K | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 340.36 M | ||||
| Total Asset | 679.32 M | ||||
| Retained Earnings | 238.36 M | ||||
| Working Capital | 266.57 M | ||||
| Current Asset | 158.75 M | ||||
| Current Liabilities | 86.05 M | ||||
| Net Asset | 679.32 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Cross Country
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.Moving together with Cross Stock
Moving against Cross Stock
| 0.81 | MD | Mednax Inc | PairCorr |
| 0.8 | ECOR | Electrocore LLC | PairCorr |
| 0.79 | ELMD | Electromed | PairCorr |
| 0.71 | DOCS | Doximity | PairCorr |
| 0.71 | VREX | Varex Imaging Corp | PairCorr |
The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.
The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cross Country Piotroski F Score and Cross Country Altman Z Score analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.